![]() |
市場調查報告書
商品編碼
1662792
2030 年手術縫合器市場預測:按產品類型、機制、應用、最終用戶和地區進行的全球分析Surgical Staplers Market Forecasts to 2030 - Global Analysis By Product (Manual Surgical Staplers and Powered Surgical Staplers), Stapler Type, Mechanism, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球手術縫合器市值為 57.2 億美元,預計到 2030 年將達到 87.6 億美元,預測期內的複合年成長率為 9.2%。
手術縫合器是醫療設備。它提供了一種比傳統縫合更快、更一致的替代方法,最大限度地減少組織創傷並縮短手術時間。這些儀器有助於精確密封內部和外部組織。縫合器有手動和電動兩種類型,以及線性、圓形和內視鏡類型,適用於各種手術,包括胃腸、胸腔外科和婦科手術。
根據美國國家醫學圖書館 2023 年的一篇論文,印度每年進行的心血管手術數量估計約為 30 萬例。
腹腔鏡和機器人手術的激增
腹腔鏡和機器人手術的激增大大增加了對先進手術器械的需求。這些微創手術需要精確、有效率、可靠的縫合裝置來縫合切口、固定組織並進行吻合。機器人輔助手術尤其推動了專用縫合器的採用,因為它們具有更高的精確度和準確度。這一趨勢加速了縫合器設計的創新,以確保與現代手術技術的兼容性,進一步推動了市場擴張。
併發症風險
手術縫合器併發症的風險,包括故障、組織密封不充分、洩漏和周圍組織損傷,會嚴重影響患者的預後,包括感染疾病、出血和延長恢復時間。這些併發症是由於儀器使用不當、故障或釘倉放置不當造成的。這樣的風險阻礙了醫療保健提供者採用手術縫合器,從而限制了其使用。隨著病患安全問題日益嚴重以及監管機構實施更嚴格的指導方針,市場正面臨採用和成長放緩的問題。
擴大醫療基礎設施
隨著醫院和診所升級到現代化、高效的設備,先進手術縫合器的需求正在增加。這些裝置可以更快、更可靠地傷口縫合,減少手術時間並改善患者的治療效果。醫療保健領域的投資正在成長,尤其是在新興國家,獲得高品質手術設備的管道也不斷改善。此外,隨著微創和機器人輔助手術的普及,對專用縫合器的需求正在增加,這進一步推動了市場成長並鼓勵採用尖端手術技術。
昂貴的設備和消耗品
由於製造程序先進、採用鈦和聚乳酸等優質材料以及精密工程,手術縫合器價格昂貴。此外,需要墨盒和訂書釘等專用零件也增加了成本。這些設備通常需要頻繁更換,為醫院和醫療保健提供者帶來高昂的成本。因此,設備和消耗品的財務負擔導致預算限制,這可能會減緩或限制某些地區和醫療保健環境中的採用,從而阻礙市場成長。
由於選擇性手術延遲、住院人數減少以及供應鏈中斷,COVID-19 疫情對手術縫合器市場產生了重大影響。許多非必要的手術,包括減肥手術和整容手術,都被推遲,從而減少了需求。不過,緊急和重症手術仍在繼續,使得市場保持活躍。此外,對感染控制和微創手術的日益重視加速了先進縫合器的採用,從而推動了市場的成長。
可重複使用手術縫合器市場預計將在預測期內成長至最大
預計可重複使用手術縫合器部分將在預測期內佔據最大的市場佔有率。可重複使用的手術縫合器是醫療設備。它們採用不銹鋼等耐用材料製成,是一種經濟高效、環保的一次性訂書機替代品。這些縫合器可以精確傷口縫合,同時減少醫療廢棄物。
預計預測期內普通外科手術部分將以最高的複合年成長率成長。
預計預測期內普通外科手術部分將呈現最高的成長率。在一般外科手術中,手術縫合器廣泛用於傷口縫合、吻合和組織切除。它比縫合線更精確,縮短了手術時間,並最大限度地減少了組織創傷。鈦釘或可吸收釘能夠提供牢固的閉合併促進癒合。
由於外科手術的增加、醫療保健投資的增加以及醫療保健基礎設施的不斷擴大,預計亞太地區將在預測期內佔據最大的市場佔有率。該地區人口老化以及癌症和肥胖症等慢性病的高發性導致手術對縫合器的需求增加。中國、印度和日本等國家是主要市場,受益於技術進步和微創手術的採用。總體而言,醫療保健服務的改善和技術創新正在推動市場擴張。
在預測期內,由於先進的醫療保健基礎設施、較高的手術量以及微創手術的廣泛採用,預計北美將呈現最高的複合年成長率。美國引領市場,這得益於慢性疾病患者數量的增加、減重相關手術以及縫合器材技術的進步。主要製造商的存在、嚴格的 FDA 法規以及對電動和吸收性訂書機的不斷成長的需求進一步推動了成長。總體而言,技術創新、人口老化和機器人輔助手術繼續推動該地區的市場擴張。
According to Stratistics MRC, the Global Surgical Staplers Market is accounted for $5.72 billion in 2024 and is expected to reach $8.76 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Surgical staplers are medical devices used to close wounds, incisions, or surgical anastomoses by applying metal or absorbable staples. They provide a faster, more consistent alternative to traditional suturing, minimizing tissue trauma and reducing operative time. These devices help seal internal and external tissues with precision. Staplers come in manual and powered variants, with linear, circular, and endoscopic designs for various procedures, including gastrointestinal, thoracic, and gynaecological surgeries.
According to a 2023 article by the National Library of Medicine, the number of cardiac procedures performed in India are estimated to be around 300,000 per year.
Surge in laparoscopic and robotic surgeries
The surge in laparoscopic and robotic surgeries significantly increases the demand for advanced surgical tools. These minimally invasive procedures require precise, efficient, and reliable stapling devices to close incisions, secure tissue, and perform anastomoses. Robotic-assisted surgeries, in particular, offer enhanced accuracy and precision, boosting the adoption of specialized staplers. This trend accelerates innovation in stapler designs, ensuring their compatibility with modern surgical techniques, which further propels market expansion.
Risk of complications
The risk of complications with surgical staplers, such as misfiring, inadequate tissue sealing, leakage, or damage to surrounding tissues, can lead to severe patient outcomes, including infections, bleeding, or longer recovery times. These complications result from improper device use, malfunction, or poor staple placement. Such risks deter healthcare providers from adopting surgical staplers, limiting their usage. As patient safety concerns rise and regulatory bodies impose stricter guidelines, the market faces slower adoption and growth.
Expanding healthcare infrastructure
As hospitals and clinics upgrade to modern, efficient equipment, the demand for advanced surgical staplers rises. These devices offer faster, more reliable wound closure, reducing surgical time and improving patient outcomes. Growing investments in healthcare, especially in emerging economies, also lead to greater access to high-quality surgical tools. Additionally, as minimally invasive and robotic-assisted surgeries gain popularity, the need for specialized staplers increases, further propelling market growth and enhancing the adoption of cutting-edge surgical technologies.
Expensive devices and consumables
Surgical staplers are expensive due to advanced manufacturing processes, high-quality materials like titanium or polylactide, and precision engineering. Additionally, the need for specialized components such as cartridges and staples add to the cost. These devices often require frequent replacement, making them costly for hospitals and healthcare providers. Therefore, the financial burden of both the devices and consumables hampers market growth, as it may lead to budgetary constraints, delaying or limiting adoption in certain regions or healthcare environments.
The covid-19 pandemic significantly impacted the surgical staplers market due to postponed elective surgeries, reduced hospital admissions, and supply chain disruptions. Many non-essential procedures, including bariatric and cosmetic surgeries, were delayed, lowering demand. However, emergency and critical surgeries continued, sustaining market activity. Additionally, increased focus on infection control and minimally invasive procedures accelerated the adoption of advanced staplers, driving market growth.
The reusable surgical staplers segment is expected to be the largest during the forecast period
The reusable surgical staplers segment is expected to account for the largest market share during the forecast period. Reusable surgical staplers are medical devices designed for multiple uses after proper sterilization. Made from durable materials like stainless steel, they offer a cost-effective and environmentally friendly alternative to disposable staplers. These staplers provide precise wound closure while reducing medical waste.
The general surgery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the general surgery segment is predicted to witness the highest growth rate. In general surgery, surgical staplers are widely used for wound closure, anastomosis, and tissue resection. They enhance precision, reduce operative time, and minimize tissue trauma compared to sutures. They provide secure closures with titanium or absorbable staples, improving healing.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing surgical procedures, rising healthcare investments, and expanding medical infrastructure. The region's aging population and higher prevalence of chronic diseases, such as cancer and obesity, drive demand for staplers in surgeries. Countries like China, India, and Japan are key markets, benefiting from technological advancements and the adoption of minimally invasive procedures. Overall, improving healthcare access and innovation fuel market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by the advanced healthcare infrastructure, high surgical volumes, and strong adoption of minimally invasive procedures. The U.S. leads the market, driven by rising chronic disease cases, obesity-related surgeries, and technological advancements in stapling devices. The presence of major manufacturers, stringent FDA regulations, and increasing demand for powered and absorbable staplers further boost growth. Overall, innovation, an aging population, and robotic-assisted surgeries continue to drive market expansion in the region.
Key players in the market
Some of the key players in Surgical Staplers market include Medtronic, Johnson & Johnson (Ethicon), 3M Company, B. Braun Melsungen AG, Conmed Corporation, Intuitive Surgical, Inc., Smith & Nephew plc, Boston Scientific Corporation, Zimmer Biomet Holdings, Inc., Meril Life Sciences Pvt. Ltd., OSSIO Inc., Frankenman International Limited, Welfare Medical Ltd., Reach Surgical, Inc., Grena Ltd., Miconvey Innovation, Panther Healthcare and Surgnova Healthcare Technologies.
In May 2024, Ethicon, a Johnson & Johnson MedTech company, launched the ECHELON LINEAR(TM) Cutter. It is the first linear cutter to market with combined innovative and proprietary technologies - 3D-Stapling Technology and Gripping Surface Technology (GST) - two advanced capabilities proven to enable greater staple line security, which can help surgeons reduce risks and support patient outcomes.
In February 2023, OSSIO Inc., announced the introduction of the new OSSIOfiber(R) Compression Staple, the next step towards becoming the gold standard in orthopedic fixation. OSSIO's fifth product family, OSSIOfiber(R) Compression Staples, allow surgeons to evolve to stronger, bio-integrative compression.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.